C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Transasia supports ‘Timeless Pankaj Udhas’ musical concert in aid of thalassemia children and celebrates a new record

Saturday, April 30, 2022

As a part of its Corporate Social Responsibility for the benefit of thalassemia children Transasia BioMedicals Ltd once again joined hands with PATUT to organize Timeless Pankaj Udhas a musical concert by the highly acclaimed Padma ShriPankaj Udhas o...

Milestone Pharmaceuticals Announces Presentation of Data from Phase 3 NODE-302 Study of Etripamil for the Treatment of PSVT

Saturday, April 30, 2022

Milestone Pharmaceuticals Inc a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines today announced data from NODE its Phase openlabel extension study of etripamil nasal spray the Company...

Recipharm offers services to enable switch to next generation pMDI propellants

Friday, April 29, 2022

Global contract development and manufacturing organisation CDMO Recipharm today announces that it is expanding its pMDI product development expertise to accommodate the increasing demand from pharmaceutical companies as they begin the transition to t...

MGI announces partnership with Nalagenetics to advance personalised medicine

Thursday, April 28, 2022

MGI a company committed to be a worldleading life science innovator today announced a partnership with Nalagenetics NALA to codevelop low coverage whole genome sequencing for risk prediction and population genomics through optimising Next Generation...

ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array™ Version 1.1

Thursday, April 28, 2022

ClearPoint Neuro Inc a global therapyenabling platform company providing navigation and delivery to the brain today announced that it has received FDA clearance for version of its next generation SmartFrame Array Neuro Navigation System and Software...

EVERSANA™ and Vector Pharma FZCO Announce Strategic Partnership to Expand Commercialisation Services Throughout Middle East and North Africa

Thursday, April 28, 2022

EVERSANA the pioneer of nextgeneration commercial services to the global life sciences industry and Vector Pharma FZCO of Dubai UAE the leading fullservice distributor for rare disease oncology and highly specialized therapeutics in the Middle East N...

Skye Bioscience Engages Clinical Trial Site for Phase 1 Study in Agreement with CMAX Clinical Research

Thursday, April 28, 2022

Skye Bioscience Inc a pharmaceutical company developing proprietary synthetic cannabinoid derivatives to treat glaucoma and other diseases with significant unmet need has retained CMAX Clinical Research CMAX to facilitate enrollment of and drug admin...

Xenetic Biosciences, Inc. Expands Oncology Pipeline with In-Licensing of DNase Based Oncology Platform Comprising Multiple Therapeutic Modalities

Wednesday, April 27, 2022

Xenetic Biosciences Inc a biopharmaceutical company focused on advancing innovative immuneoncology technologies for the treatment of hard to treat cancers today announced that it has entered into exclusive license and sublicense agreements with CLS T...

Fennec Pharmaceuticals Announces FDA Acceptance for Filing of New Drug Application Resubmission for PEDMARK™

Wednesday, April 27, 2022

Fennec Pharmaceuticals Inc a specialty pharmaceutical company today announced that the US Food and Drug Administration FDA has accepted for filing the Companys resubmitted New Drug Application NDA for PEDMARKTM a unique formulation of sodium thiosulf...

Caladrius Biosciences and Cend Therapeutics Announce Definitive Merger Agreement

Wednesday, April 27, 2022

Caladrius Biosciences Inc a clinicalstage biopharmaceutical company dedicated to the development of innovative therapies designed to treat or reverse disease and Cend Therapeutics Inc Cend a privatelyheld clinicalstage biotechnology company focused o...